Pharmaceutical drug

English:

2-Thiophenesulfonamide, 5-methyl-N-[2-(1-piperidinyl)phenyl]-^(CAS)

;

5-Methyl-N-[2-(1-piperidinyl)phenyl]-2-thiophenesulfonamide^(IUPAC)

;

MK6-83 [Wiki]

;

MK683

;

French:

5-Méthyl-N-[2-(1-pipéridinyl)phényl]-2-thiophènesulfonamide^(IUPAC)

;

German:

5-Methyl-N-[2-(1-piperidinyl)phenyl]-2-thiophensulfonamid^(IUPAC)

;

English:

Benzenesulfonamide, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]cyclohexyl]-^(CAS)

;

ML-SI3 [Wiki]

;

N-[2-[4-(2-methoxyphenyl)piperazin-1-yl]cyclohexyl]benzenesulfonamide^(IUPAC)

;

N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzenesulfonamide^(IUPAC)

;

French:

N-{2-[4-(2-Méthoxyphényl)-1-pipérazinyl]cyclohexyl}benzènesulfonamide^(IUPAC)

;

German:

N-{2-[4-(2-Methoxyphenyl)-1-piperazinyl]cyclohexyl}benzolsulfonamid^(IUPAC)

;

English:

Acetamide, N-[3-[4-[4-[[(cyclohexylmethyl)sulfonyl]amino]butyl]-1-piperazinyl]phenyl]-^(CAS)

;

N-(3-(4-(4-cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl)phenyl)acetamide

;

N-[3-[4-[4-[[(Cyclohexylmethyl)sulfonyl]amino]butyl]-1-piperazinyl]phenyl]acetamide

;

N-{3-[4-(4-{[(Cyclohexylmethyl)sulfonyl]amino}butyl)-1-piperazinyl]phenyl}acetamide^(IUPAC)

;

N-{3-[4-(4-{[(cyclohexylmethyl)sulfonyl]amino}butyl)piperazin-1-yl]phenyl}acetamide

;

Naluzotan [Wiki]

;

PRX-00023

;

German:

N-{3-[4-(4-{[(Cyclohexylmethyl)sulfonyl]amino}butyl)-1-piperazinyl]phenyl}acetamid^(IUPAC)

;

French:

N-{3-[4-(4-{[(Cyclohexylméthyl)sulfonyl]amino}butyl)-1-pipérazinyl]phényl}acétamide^(IUPAC)

;

Naluzotan

;

Español:

Naluzotán

;

Latina:

Naluzotanum

;

Русский:

налузотан

;

العربية:

نالوزوتان

;

中文:

纳鲁佐坦

;

English:

1H-Indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-^(CAS)

;

Amerge

;

Colatan

;

N-Methyl-2-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]ethanesulfonamide^(IUPAC)

;

N-Methyl-2-[3-(1-methylpiperidin-4-yl)-1H-indol-5-yl]ethanesulfonamide

;

N-Methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide

;

Naramig

;

Naratriptan [Wiki]

;

العربية:

ناراتريبتان [Wiki]

;

German:

N-Methyl-2-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]ethansulfonamid^(IUPAC)

;

Naratriptan [Wiki]

;

Español:

Naratriptán [Wiki]

;

Italiano:

Naratriptan [Wiki]

;

Português:

Naratriptano [Wiki]

;

French:

N-Méthyl-2-[3-(1-méthyl-4-pipéridinyl)-1H-indol-5-yl]éthanesulfonamide^(IUPAC)

;

Русский:

наратриптан

;

中文:

那拉曲坦

;

English:

4-(4-{[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl}-1-piperazinyl)-N-[(4-{[(2R)-4-(4-morpholinyl)-1-(phenylsulfanyl)-2-butanyl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamid e^(IUPAC)

;

4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide

;

ABT-263

;

ABT263

;

AOB1912

;

Benzamide, 4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfon yl]-^(CAS)

;

C47H55ClF3N5O6S3

;

EX-A055

;

Navitoclax [Wiki]

;

UBX0101

;

Русский:

Навитоклакс [Wiki]

;

French:

4-(4-{[2-(4-Chlorophényl)-5,5-diméthyl-1-cyclohexén-1-yl]méthyl}-1-pipérazinyl)-N-[(4-{[(2R)-4-(4-morpholinyl)-1-(phénylsulfanyl)-2-butanyl]amino}-3-[(trifluorométhyl)sulfonyl]phényl)sulfonyl]benzamid e^(IUPAC)

;

Navitoclax

;

German:

4-(4-{[2-(4-Chlorphenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl}-1-piperazinyl)-N-[(4-{[(2R)-4-(4-morpholinyl)-1-(phenylsulfanyl)-2-butanyl]amino}-3-[(trifluormethyl)sulfonyl]phenyl)sulfonyl]benzamid^(IUPAC)

;

Español:

Navitoclax

;

Latina:

Navitoclaxum

;

English:

Methanesulfonamide, N-[2-(cyclohexyloxy)-4-nitrophenyl]-^(CAS)

;

N-(2-Cyclohexyloxy-4-nitro-phenyl)-; methanesulfonamide

;

N-[2-(Cyclohexyloxy)-4-nitrophenyl]methanesulfonamide^(IUPAC)

;

NS 398

;

NS-398 [Wiki]

;

Tocris-0942

;

French:

N-[2-(Cyclohexyloxy)-4-nitrophényl]méthanesulfonamide^(IUPAC)

;

German:

N-[2-(Cyclohexyloxy)-4-nitrophenyl]methansulfonamid^(IUPAC)

;

English:

Methanesulfonamide, N-[6-[(6aR,10aR)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-3-yl]-4-hexyn-1-yl]-^(CAS)

;

N-[6-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c][1]benzopyran-3-yl]hex-4-ynyl]methanesulfonamide

;

N-{6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-3-yl]-4-hexyn-1-yl}methanesulfonamide^(IUPAC)

;

N-{6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-3-yl]hex-4-yn-1-yl}methanesulfonamide

;

O-2050 [Wiki]

;

[1883545-42-3]

;

[851320-29-1]

;

German:

N-{6-[(6aR,10aR)-1-Hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-3-yl]-4-hexin-1-yl}methansulfonamid^(IUPAC)

;

French:

N-{6-[(6aR,10aR)-1-Hydroxy-6,6,9-triméthyl-6a,7,10,10a-tétrahydro-6H-benzo[c]chromén-3-yl]-4-hexyn-1-yl}méthanesulfonamide^(IUPAC)

;

English:

Apoquel

;

Cyclohexanemethanesulfonamide, N-methyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-, trans-^(CAS)

;

JAKi

;

N-Methyl-1-(trans-4-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclohexyl)methanesulfonamide

;

N-Methyl-1-{trans-4-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methanesulfonamide^(IUPAC)

;

N-Methyl-1-{trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methanesulfonamide^(IUPAC)

;

Oclacitinib [Wiki]

;

PF-03394197

;

French:

N-Méthyl-1-{trans-4-[méthyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}méthanesulfonamide^(IUPAC)

;

N-Méthyl-1-{trans-4-[méthyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}méthanesulfonamide^(IUPAC)

;

Oclacitinib

;

German:

N-Methyl-1-{trans-4-[methyl(1H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methansulfonamid^(IUPAC)

;

N-Methyl-1-{trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methansulfonamid^(IUPAC)

;

Español:

Oclacitinib

;

Latina:

Oclacitinibum

;

Русский:

оклацитиниб

;

العربية:

أوكلاسيتينيب

;

中文:

奥拉替尼

;

English:

(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine^(IUPAC)

;

2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-, (2R,3S,5R)-^(CAS)

;

C17H20F2N4O3S

;

EX-A395

;

MK-3102

;

Omarigliptin [Wiki]

;

中文:

奥格列汀 [Wiki]

;

French:

(2R,3S,5R)-2-(2,5-Difluorophényl)-5-[2-(méthylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tétrahydro-2H-pyran-3-amine^(IUPAC)

;

Omarigliptine

;

German:

(2R,3S,5R)-2-(2,5-Difluorphenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amin^(IUPAC)

;

Español:

Omarigliptina

;

Latina:

Omarigliptinum

;

Русский:

омариглиптин

;

العربية:

أوماريقليبتين

;

English:

DE-117

;

Eybelis

;

Glycine, N-[6-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]-, 1-methylethyl ester^(CAS)

;

Isopropyl N-[6-({[4-(1H-pyrazol-1-yl)benzyl](3-pyridinylsulfonyl)amino}methyl)-2-pyridinyl]glycinate^(IUPAC)

;

N-[6-[[[[4-(1H-Pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]-2-pyridinyl]glycine 1-methylethyl ester

;

Omidenapag isopropyl

;

Omidenepag isopropyl [Wiki]

;

German:

Isopropyl-N-[6-({[4-(1H-pyrazol-1-yl)benzyl](3-pyridinylsulfonyl)amino}methyl)-2-pyridinyl]glycinat^(IUPAC)

;

French:

N-[6-({[4-(1H-Pyrazol-1-yl)benzyl](3-pyridinylsulfonyl)amino}méthyl)-2-pyridinyl]glycinate d'isopropyle^(IUPAC)

;

Русский:

Омиденепаг изопропил

;

Эйбелис

;

English:

3,5-Dinitro-N(sup 4),N(sup 4)-dipropylsulfanilamide

;

3,5-Dinitro-N4,N4-dipropylsulfanilamide

;

3,5-Dinitro-N4,N4-dipropylsulphanilamide

;

4-(Dipropylamino)-3,5-dinitrobenzenesulfonamide^(IUPAC)

;

Benzenesulfonamide, 4-(dipropylamino)-3,5-dinitro-^(CAS)

;

Caswell No. 623A

;

EINECS:242-777-0

;

EL 119

;

N4,N4-Dipropyl-3,5-dinitrosulfanilamide

;

Oryzalin [Wiki]

;

Rizelan

;

Rycelan

;

Rycelon

;

Ryzelan

;

German:

4-(Dipropylamino)-3,5-dinitrobenzolsulfonamid^(IUPAC)

;

Oryzalin [Wiki]

;

French:

4-(Dipropylamino)-3,5-dinitrobenzènesulfonamide^(IUPAC)

;

Oryzalin [Wiki]

;

English:

3-[(Methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide^(IUPAC)

;

4-Quinolinecarboxamide, 3-[(methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]-^(CAS)

;

AZ-12472520

;

AZD-2624

;

AZD-4901

;

MLE-4901

;

Pavinetant [Wiki]

;

Русский:

Павинетант

;

German:

3-[(Methylsulfonyl)amino]-2-phenyl-N-[(1S)-1-phenylpropyl]-4-chinolincarboxamid^(IUPAC)

;

French:

3-[(Méthylsulfonyl)amino]-2-phényl-N-[(1S)-1-phénylpropyl]-4-quinoléinecarboxamide^(IUPAC)

;

pavinétant

;

Español:

pavinetant

;

Latina:

pavinetantum

;

中文:

帕维奈坦

;

English:

5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide

;

5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide^(IUPAC)

;

5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide

;

Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-^(CAS)

;

Pazopanib [Wiki]

;

Votrient

;

German:

5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzolsulfonamid^(IUPAC)

;

Pazopanib [Wiki]

;

Español:

Pazopanib [Wiki]

;

French:

5-({4-[(2,3-Diméthyl-2H-indazol-6-yl)(méthyl)amino]-2-pyrimidinyl}amino)-2-méthylbenzènesulfonamide^(IUPAC)

;

Pazopanib [Wiki]

;

日本語:

パゾパニブ [Wiki]

;

Português:

Pazopanibe [Wiki]

;

Русский:

Пазопаниб [Wiki]

;

العربية:

بازوبانيب

;

中文:

帕唑帕尼

;

English:

2-[2,6-Difluoro-4-({2-[(phenylsulfonyl)amino]ethyl}sulfanyl)phenoxy]acetamide^(IUPAC)

;

2-[2,6-Difluoro-4-[[2-[(phenylsulfonyl)amino]ethyl]thio]phenoxy]acetamide

;

4-(2-(phenylsulfonylamino)ethylthio)-2,6-difluorophenoxyacetamide

;

4-[2-(Phenylsulfonylamino)ethylthio]-2,6-difluorophenoxyacetamide

;

Acetamide, 2-[2,6-difluoro-4-[[2-[(phenylsulfonyl)amino]ethyl]thio]phenoxy]-^(CAS)

;

PEPA

;

PEPA (drug) [Wiki]

;

German:

2-[2,6-Difluor-4-({2-[(phenylsulfonyl)amino]ethyl}sulfanyl)phenoxy]acetamid^(IUPAC)

;

French:

2-[2,6-Difluoro-4-({2-[(phénylsulfonyl)amino]éthyl}sulfanyl)phénoxy]acétamide^(IUPAC)

;

English:

1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonamide^(IUPAC)

;

1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-^(CAS)

;

C4F9SO2NH2

;

FBSA

;

H-FBSA

;

Perfluorobutane sulfonamide [Wiki]

;

Perfluorobutanesulfonamide

;

German:

1,1,2,2,3,3,4,4,4-Nonafluor-1-butansulfonamid^(IUPAC)

;

French:

1,1,2,2,3,3,4,4,4-Nonafluoro-1-butanesulfonamide^(IUPAC)

;

Русский:

Перфторбутансульфонамид

;

English:

1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluoro-1-octanesulfonamide^(IUPAC)

;

1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane-1-sulfonamide

;

1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-^(CAS)

;

C8H2F17NO2S

;

Heptadecafluorooctanesulphonamide

;

PFOSA

;

Perfluoroctylsulfonamide

;

Perfluorooctane sulfonamide

;

Perfluorooctanesulfonamide [Wiki]

;

Perfluorooctanesulfonic acid amide

;

Perfluorooctanesulphonamide

;

RG9701400

;

Русский:

ПФОСА

;

Перфтороктансульфонамид

;

German:

1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadecafluor-1-octansulfonamid^(IUPAC)

;

Perfluoroctansulfonamid [Wiki]

;

French:

1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-Heptadécafluoro-1-octanesulfonamide^(IUPAC)

;

Perfluorooctanesulfonamide [Wiki]

;

中文:

全氟辛烷磺胺 [Wiki]

;

English:

2-Methyl-N-{[2'-(1-pyrrolidinylsulfonyl)-4-biphenylyl]methyl}-1-propanamine^(IUPAC)

;

PF-4455242 [Wiki]

;

[1,1'-Biphenyl]-4-methanamine, N-(2-methylpropyl)-2'-(1-pyrrolidinylsulfonyl)-^(CAS)

;

German:

2-Methyl-N-{[2'-(1-pyrrolidinylsulfonyl)-4-biphenylyl]methyl}-1-propanamin^(IUPAC)

;

French:

2-Méthyl-N-{[2'-(1-pyrrolidinylsulfonyl)-4-biphénylyl]méthyl}-1-propanamine^(IUPAC)

;

English:

4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide^(IUPAC)

;

Benzenesulfonamide, 4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-4-thiazolyl-^(CAS)

;

PF-05089771 [Wiki]

;

French:

4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophénoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzènesulfonamide^(IUPAC)

;

German:

4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorphenoxy]-5-chlor-2-fluor-N-(1,3-thiazol-4-yl)benzolsulfonamid^(IUPAC)

;

English:

Benzenesulfohydroxamic Acid

;

Benzenesulfonamide, N-hydroxy-^(CAS)

;

EINECS:209-973-8

;

N-Hydroxy-benzenesulfonamide

;

N-Hydroxybenzenesulfonamide^(IUPAC)

;

Piloty's acid [Wiki]

;

benzenesulphonohydroxamic acid

;

French:

N-Hydroxybenzènesulfonamide^(IUPAC)

;

German:

N-Hydroxybenzolsulfonamid^(IUPAC)

;

Русский:

Кислота Пилоти

;

English:

4-[3-(3-Fluoro-phenyl)-5,5-dimethyl-4-oxo-4,5-dihydro-furan-2-yl]-benzenesulfonamide

;

4-[3-(3-Fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydro-2-furanyl]benzenesulfonamide^(IUPAC)

;

4-[3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl]benzenesulfonamide

;

Acelex

;

Benzenesulfonamide, 4-[3-(3-fluorophenyl)-4,5-dihydro-5,5-dimethyl-4-oxo-2-furanyl]-^(CAS)

;

CG100649

;

Polmacoxib [Wiki]

;

French:

4-[3-(3-Fluorophényl)-5,5-diméthyl-4-oxo-4,5-dihydro-2-furanyl]benzènesulfonamide^(IUPAC)

;

Polmacoxib

;

German:

4-[3-(3-Fluorphenyl)-5,5-dimethyl-4-oxo-4,5-dihydro-2-furanyl]benzolsulfonamid^(IUPAC)

;

Español:

Polmacoxib

;

Latina:

Polmacoxibum

;

Русский:

полмакоксиб

;

العربية:

بولماكوكسيب

;

中文:

帕马考昔

;